CHRISTINE DALVA: Open Payments
NPI 1942690599 · UKIAH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 14 payments from 9 companies in 2025. Trend: 2023 $446 · 2024 $795 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $90 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| MIMEDX Group, Inc. | 1 | $43 |
| GENZYME CORPORATION | 1 | $37 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $31 |
| Amgen Inc. | 1 | $25 |
| UCB, Inc. | 1 | $24 |
| Organon LLC | 1 | $6 |
Products named: BOTOX, DUPIXENT, Zoryve, Rhapsido, EBGLYSS, RINVOQ, Otezla, Bimzelx.
Industry payments across CA — which companies pay providers there.
